MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Jan 11

PMID 38201661

Authors

Mohamed Ali Hussein

Kamyab Valinezhad

Eman Adel

Gnanasekar Munirathinam

Affiliations

Soon will be listed here.

Abstract

Metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) is a long intergenic non-coding RNA (lncRNA) located on chr11q13. It is overexpressed in several cancers and controls gene expression through chromatin modification, transcriptional regulation, and post-transcriptional regulation. Importantly, MALAT-1 stimulates cell proliferation, migration, and metastasis and serves a vital role in driving the epithelial-to-mesenchymal transition (EMT), subsequently acquiring cancer stem cell-like properties and developing drug resistance. MALAT-1 modulates EMT by interacting with various intracellular signaling pathways, notably the phosphoinositide 3-kinase (PI3K)/Akt and Wnt/β-catenin pathways. It also behaves like a sponge for microRNAs, preventing their interaction with target genes and promoting EMT. In addition, we have used bioinformatics online tools to highlight the disparities in the expression of MALAT-1 between normal and cancer samples using data from The Cancer Genome Atlas (TCGA). Furthermore, the intricate interplay of MALAT-1 with several essential targets of cancer progression and metastasis renders it a good candidate for therapeutic interventions. Several innovative approaches have been exploited to target MALAT-1, such as short hairpin RNAs (shRNAs), antisense oligonucleotides (ASOs), and natural products. This review emphasizes the interplay between MALAT-1 and EMT in modulating cancer metastasis, stemness, and chemoresistance in different cancers.

Citing Articles

Interaction Between Malat1 and miR-499-5p Regulates Meis1 Expression and Function with a Net Impact on Cell Proliferation.

Fahim S, Ragheb M, Fayed I, Osama A, Karam A, Magdeldin S Cells. 2025; 14(2).

PMID: 39851553 PMC: 11764005. DOI: 10.3390/cells14020125.

Evaluation of exo-long noncoding RNA MALAT1 in OSCC in comparison to dysplastic and normal: A cross-sectional study.

Sekar R, Jayaraman S, Veeraraghavan V, Krishnamoorthy K, Aramanai S, Natarajan S J Oral Biol Craniofac Res. 2025; 15(1):123-128.

PMID: 39850457 PMC: 11754077. DOI: 10.1016/j.jobcr.2024.12.018.

Epithelial‑derived head and neck squamous tumourigenesis (Review).

Shirima C, Bleotu C, Spandidos D, El-Naggar A, Gradisteanu Pircalabioru G, Michalopoulos I Oncol Rep. 2024; 52(4).

PMID: 39219259 PMC: 11358675. DOI: 10.3892/or.2024.8800.

Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets.

Li X, Wu Y, Jin Y Noncoding RNA Res. 2024; 9(4):1069-1079.

PMID: 39022675 PMC: 11254510. DOI: 10.1016/j.ncrna.2024.06.010.

Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths.

Hjazi A, Jasim S, Altalbawy F, Kaur H, Hamzah H, Kaur I Cell Biochem Biophys. 2024; 82(3):1613-1627.

PMID: 38806965 DOI: 10.1007/s12013-024-01317-6.

References

Tang X, Wang W, Hann S . Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie. 2019; 163:58-72. DOI: 10.1016/j.biochi.2019.05.010. View

Shi B, Wang Y, Yin F . MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells. Cancer Biol Ther. 2017; 18(10):792-800. PMC: 5678686. DOI: 10.1080/15384047.2017.1373214. View

Tang Y, Xiao G, Chen Y, Deng Y . LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Anticancer Drugs. 2018; 29(8):725-735. DOI: 10.1097/CAD.0000000000000650. View

Shi C, Zheng Y, Pan F, Zhang F, Zhuang P, Fu W . Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma. Front Pharmacol. 2021; 12:708967. PMC: 8526893. DOI: 10.3389/fphar.2021.708967. View

Yang Z, Xie Q, Chen Z, Ni H, Xia L, Zhao Q . Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition. Exp Ther Med. 2019; 17(3):1569-1578. PMC: 6364244. DOI: 10.3892/etm.2018.7142. View

Garside V, Chang A, Karsan A, Hoodless P . Co-ordinating Notch, BMP, and TGF-β signaling during heart valve development. Cell Mol Life Sci. 2012; 70(16):2899-917. PMC: 4996658. DOI: 10.1007/s00018-012-1197-9. View

Levy D, Lee C . What does Stat3 do?. J Clin Invest. 2002; 109(9):1143-8. PMC: 150972. DOI: 10.1172/JCI15650. View

Anbiyaee O, Moalemnia A, Ghaedrahmati F, Khombi Shooshtari M, Khoshnam S, Kempisty B . The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma. BMC Nephrol. 2023; 24(1):380. PMC: 10731893. DOI: 10.1186/s12882-023-03438-1. View

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

10.

Zhou J, Wang J, Zeng Y, Zhang X, Hu Q, Zheng J . Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer. Oncotarget. 2015; 6(42):44332-45. PMC: 4792560. DOI: 10.18632/oncotarget.6293. View

11.

Duan W, Du L, Jiang X, Wang R, Yan S, Xie Y . Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 2016; 7(48):78850-78858. PMC: 5346682. DOI: 10.18632/oncotarget.12880. View

12.

Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X . MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 2014; 36(3):1477-86. DOI: 10.1007/s13277-014-2631-4. View

13.

Hartford C, Lal A . When Long Noncoding Becomes Protein Coding. Mol Cell Biol. 2020; 40(6). PMC: 7048269. DOI: 10.1128/MCB.00528-19. View

14.

Zeng L, Cen Y, Chen J . Long non-coding RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes in breast cancer cells. Oncol Lett. 2018; 15(2):2117-2122. PMC: 5777122. DOI: 10.3892/ol.2017.7557. View

15.

Li L, Chai Y, Guo X, Chu S, Zhang L . RETRACTED: The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother. 2017; 89:939-948. DOI: 10.1016/j.biopha.2017.02.011. View

16.

Gillan L, Matei D, Fishman D, Gerbin C, Karlan B, Chang D . Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 2002; 62(18):5358-64. View

17.

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F . Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012; 8(9):2289-94. DOI: 10.1039/c2mb25070e. View

18.

Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L . Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway. PLoS One. 2013; 8(11):e78700. PMC: 3823921. DOI: 10.1371/journal.pone.0078700. View

19.

Miao S, Bhunia D, Devari S, Liang Y, Munyaradzi O, Rundell S . Bifacial PNAs Destabilize MALAT1 by 3' A-Tail Displacement from the U-Rich Internal Loop. ACS Chem Biol. 2021; 16(8):1600-1609. PMC: 8505731. DOI: 10.1021/acschembio.1c00575. View

20.

Calin G, Liu C, Sevignani C, Ferracin M, Felli N, Dumitru C . MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004; 101(32):11755-60. PMC: 511048. DOI: 10.1073/pnas.0404432101. View